Moderna Biopharma Canada Corporation
Registration:
14
of
16
(2024-04-23
to
2024-07-08)
Details Regarding the Identified Subject Matter
Subject matters
|
Details
|
Categories
|
Research and Development, Science and Technology
|
Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
|
Policies or Program
|
Government Procurement, Health
|
Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models
|
Policies or Program
|
Economic Development, Health
|
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada
|
Policies or Program
|